This is a match-making section for JPIAMR 17th call - AMR Interventions 2024 (IMPACT).
Human Health
Animal Health (incl. wildlife, livestock, acquatic organisms, and companion animals)Clinical Microbiology; Antimicrobial Resistance; Molecular Epidemiology; Infrared spectroscopy; Diagnostics
I have experience in culturomics, antibiotic susceptibility methods, strain typing methods applied to explain the selection and dissemination of antimicrobial resistant (AMR) bacteria of clinical relevance, using a state-of-the art approach including genomics in close proximity to different healthcare settings. Track record of the development of cost-effective methods for diagnosis and typing of AMR (Blue-Carba test for carbapenemase detection-https://journals.asm.org/doi/10.1128/jcm.01634-13; FT-IR spectroscopy for bacterial typing-doi: 10.1007/s10096-018-3431-3) that are being applied as instruments for a quicker and more effective infection control in hospital settings (10.3390/antibiotics11010092; 10.3390/antibiotics9110806; 10.1007/s10096-020-03956-y).
My expertise could be valuable to assess rates and trends of antimicrobial resistant (AMR) bacteria by state-of-the-art phenotypic and genotypic methods as an evaluation of a given strategy to prevent and control the spread of AMR bacteria. I have been implementing FT-IR spectroscopy as a low-cost, quick and effective method to support infection control and surveillance of AMR bacteria, together with a hospital partners and key agents in implementing stewardship and infection control policies and approaches. These network in Portugal can be valuable to assess representativeness throughout Europe according to variable clinical and public health practices.
Submitted on 2024-01-19 15:43:07
« Return to the partner search tool